Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
29
CYH Quote, Financials, Valuation and Earnings
Last price:
$2.73
Seasonality move
:
1.76%
Day range:
$2.61 - $2.77
52-week range:
$2.24 - $6.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
--
Volume:
2.6M
Avg. volume:
2.8M
1-year change:
-17.27%
Market cap:
$383M
Revenue:
$12.6B
EPS (TTM):
-$3.68
Analysts' Opinion
-
Consensus RatingCommunity Health Systems has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 4 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $4.00, Community Health Systems has an estimated upside of 46.52% from its current price of $2.73.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $2.73.
Fair Value
-
According to the consensus of 7 analysts, Community Health Systems has 46.52% upside to fair value with a price target of $4.00 per share.
CYH vs. S&P 500
-
Over the past 5 trading days, Community Health Systems has overperformed the S&P 500 by 11.46% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Community Health Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Community Health Systems has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Community Health Systems reported revenues of $3.2B.
Earnings Growth
-
Community Health Systems earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Community Health Systems reported earnings per share of -$0.10.
Enterprise value:
11.9B
EV / Invested capital:
1.19x
Price / LTM sales:
0.03x
EV / EBIT:
18.76x
EV / Revenue:
0.94x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
78.15x
Price / Operating cash flow:
2.38x
Enterprise value / EBITDA:
10.70x
Gross Profit (TTM):
$10.7B
Return On Assets:
-3.45%
Net Income Margin (TTM):
-3.85%
Return On Equity:
--
Return On Invested Capital:
-4.71%
Operating Margin:
8.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $12.2B | $12.5B | $12.7B | $3.1B | $3.2B | |
| Gross Profit | $10.2B | $10.5B | $10.7B | $2.7B | $2.7B | |
| Operating Income | $679M | $929M | $855M | $248M | $260M | |
| EBITDA | $1.7B | $1.5B | $1.1B | $348M | $391M | |
| Diluted EPS | -$0.06 | -$0.95 | -$3.68 | -$0.32 | -$0.10 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.1B | $3.5B | $3.1B | $3.2B | $3.4B | |
| Total Assets | $15.6B | $15.3B | $14.6B | $14.4B | $13.9B | |
| Current Liabilities | $2.7B | $2.3B | $2.1B | $2.1B | $2.4B | |
| Total Liabilities | $16.7B | $16.1B | $15.4B | $15.3B | $15.2B | |
| Total Equity | -$1.1B | -$819M | -$791M | -$878M | -$1.3B | |
| Total Debt | $11.9B | $12.2B | $11.7B | $11.6B | $11.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $204M | $301M | $504M | $96M | $120M | |
| Cash From Investing | -$157M | -$106M | $268M | -$99M | $444M | |
| Cash From Financing | -$363M | -$291M | -$389M | $13M | -$170M | |
| Free Cash Flow | -$236M | -$137M | $152M | $3M | $35M | |
CYH
Sector
Market Cap
$383M
$34.9M
Price % of 52-Week High
43.4%
44.35%
Dividend Yield
0%
0%
Shareholder Yield
19.02%
-0.82%
1-Year Price Total Return
-17.27%
-38.5%
Beta (5-Year)
1.993
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.61
200-day SMA
Sell
Level
$3.95
Bollinger Bands (100)
Sell
Level
2.67 - 3.39
Chaikin Money Flow
Sell
Level
-4.7M
20-day SMA
Buy
Level
$2.55
Relative Strength Index (RSI14)
Buy
Level
53.70
ADX Line
Buy
Level
28.72
Williams %R
Neutral
Level
-48.6339
50-day SMA
Sell
Level
$2.81
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
2.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7266)
Sell
CA Score
(Annual)
Level (-2.7617)
Buy
Beneish M-Score
(Annual)
Level (-2.7503)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.7991)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
Stock Forecast FAQ
In the current month, CYH has received 2 Buy ratings 4 Hold ratings, and 1 Sell ratings. The CYH average analyst price target in the past 3 months is $4.00.
-
Where Will Community Health Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Community Health Systems share price will rise to $4.00 per share over the next 12 months.
-
What Do Analysts Say About Community Health Systems?
Analysts are divided on their view about Community Health Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Community Health Systems is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is Community Health Systems's Price Target?
The price target for Community Health Systems over the next 1-year time period is forecast to be $4.00 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CYH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Community Health Systems is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CYH?
You can purchase shares of Community Health Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Community Health Systems shares.
-
What Is The Community Health Systems Share Price Today?
Community Health Systems was last trading at $2.73 per share. This represents the most recent stock quote for Community Health Systems. Yesterday, Community Health Systems closed at $2.73 per share.
-
How To Buy Community Health Systems Stock Online?
In order to purchase Community Health Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
20
EVVTY alert for May 1
Evolution AB [EVVTY] is down 19.01% over the past day.
Sell
47
LANC alert for May 1
Lancaster Colony [LANC] is down 15.56% over the past day.
Sell
36
BHE alert for May 1
Benchmark Electronics [BHE] is down 15.02% over the past day.
